FI955256A - Skvaleenisyntaasin fosfonosulfonaatti-inhibiittorin suoloja ja menetelmä - Google Patents

Skvaleenisyntaasin fosfonosulfonaatti-inhibiittorin suoloja ja menetelmä Download PDF

Info

Publication number
FI955256A
FI955256A FI955256A FI955256A FI955256A FI 955256 A FI955256 A FI 955256A FI 955256 A FI955256 A FI 955256A FI 955256 A FI955256 A FI 955256A FI 955256 A FI955256 A FI 955256A
Authority
FI
Finland
Prior art keywords
phosphonosulfonate
inhibitor
salts
squalene synthase
squalene
Prior art date
Application number
FI955256A
Other languages
English (en)
Swedish (sv)
Other versions
FI955256A0 (fi
Inventor
Yadagiri Pendri
Chung-Pin Chen
David J Kucera
Eduardo J Martinez
Paul D Pansegrau
John K Thottathil
Peter Timmins
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of FI955256A0 publication Critical patent/FI955256A0/fi
Publication of FI955256A publication Critical patent/FI955256A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4056Esters of arylalkanephosphonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4071Esters thereof the ester moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4075Esters with hydroxyalkyl compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
FI955256A 1994-11-03 1995-11-02 Skvaleenisyntaasin fosfonosulfonaatti-inhibiittorin suoloja ja menetelmä FI955256A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33366194A 1994-11-03 1994-11-03

Publications (2)

Publication Number Publication Date
FI955256A0 FI955256A0 (fi) 1995-11-02
FI955256A true FI955256A (fi) 1996-05-04

Family

ID=23303735

Family Applications (1)

Application Number Title Priority Date Filing Date
FI955256A FI955256A (fi) 1994-11-03 1995-11-02 Skvaleenisyntaasin fosfonosulfonaatti-inhibiittorin suoloja ja menetelmä

Country Status (14)

Country Link
EP (1) EP0710665A1 (fi)
JP (1) JPH08208672A (fi)
KR (1) KR960017680A (fi)
CN (1) CN1130188A (fi)
AU (1) AU3458795A (fi)
CA (1) CA2159850A1 (fi)
CZ (1) CZ279595A3 (fi)
FI (1) FI955256A (fi)
HU (1) HUT73140A (fi)
IL (1) IL115537A0 (fi)
NO (1) NO954389L (fi)
PL (1) PL311218A1 (fi)
TW (1) TW318852B (fi)
ZA (1) ZA959326B (fi)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2780974B1 (fr) * 1998-07-08 2001-09-28 Sod Conseils Rech Applic Utilisation de derives d'imidazopyrazines pour preparer un medicament destine a traiter les pathologies qui resultent de la formation de la proteine g heterotrimetrique
WO2002038180A1 (fr) * 2000-11-09 2002-05-16 Takeda Chemical Industries, Ltd. Agent haute densite faisant monter le taux de lipoproteine-cholesterol
WO2007075186A2 (en) 2005-04-18 2007-07-05 The Regents Of The University Of California Antimicrobial therapy for bacterial infections
JP5161872B2 (ja) * 2006-05-12 2013-03-13 ザ レジェンツ オブ ザ ユニヴァースティ オブ カリフォルニア 細菌感染に対する抗微生物療法
CN101580472B (zh) * 2009-06-24 2013-07-10 广西壮族自治区化工研究院 1,1'-联-2-萘酚的拆分剂以及拆分方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2107644A1 (en) * 1992-10-28 1994-04-29 David R. Magnin .alpha.-phosphonosulfonae squalene synthetase inhibitors and methd
US5312814A (en) * 1992-12-09 1994-05-17 Bristol-Myers Squibb Co. α-phosphonocarboxylate squalene synthetase inhibitors

Also Published As

Publication number Publication date
KR960017680A (ko) 1996-06-17
CZ279595A3 (en) 1996-08-14
NO954389D0 (no) 1995-11-02
IL115537A0 (en) 1996-01-19
JPH08208672A (ja) 1996-08-13
CN1130188A (zh) 1996-09-04
NO954389L (no) 1996-05-06
HU9503136D0 (en) 1995-12-28
CA2159850A1 (en) 1996-05-04
HUT73140A (en) 1996-06-28
PL311218A1 (en) 1996-05-13
AU3458795A (en) 1996-05-09
EP0710665A1 (en) 1996-05-08
TW318852B (fi) 1997-11-01
FI955256A0 (fi) 1995-11-02
ZA959326B (en) 1997-05-05

Similar Documents

Publication Publication Date Title
EE9700182A (et) Mikrosoomse triglütseriidi transportproteiini inhibiitorid ja meetod
EP1039890A4 (en) METFORMIN SALTS AND METHOD
EE9600194A (et) Isekleepuv mark ja meetod selle valmistamiseks
NO963860D0 (no) Isoprenyl-transferase-inhibitorer
NO2008002I2 (no) Protiokonazol og salter derav
FI951340A0 (fi) SOI-substraatti ja menetelmä sen valmistamiseksi
DE69413656D1 (de) Laseraufzeichnungsverfahren und wässrige Laseraufzeichnungszusammensetzung
FI951431A (fi) Elatusaine ja menetelmä salmonellojen tunnistamiseksi
FI971495A0 (fi) Vaahdonestokoostumus ja sen käyttömenetelmä
FI980246A0 (fi) Menetelmä keittimen käyttämiseksi ja keitin
EE03391B1 (et) Aminoetüületanoolamiini ja/või hüdroksüetüülpiperasiini saamise meetod
FI963811A (fi) Menetelmät kalpaiinin aktivoitumisen ilmaisemiseksi ja kalpaiinin inhibiittoreiden tunnistamiseksi
FI972696A0 (fi) Naftyyli-bentsoksatsepiinit tai -bentsotiatsepiinit
TR199501429A2 (tr) Matriks metaloproteaz inhibitörlerinin yerine gecen 4-biarilpentanoik asitleri ve türevleri
FI955256A (fi) Skvaleenisyntaasin fosfonosulfonaatti-inhibiittorin suoloja ja menetelmä
FI972388A0 (fi) Biofilmin välttäminen ja poistomenetelmä ja -koostumus
DK0623614T3 (da) 4-aryl-4-hydroxy-tetrahydropyraner og 3-aryl-3-hydroxy-tetrahydrofuraner som inhibitorer for 5-lipoxygenase
FI940403A (fi) Elliptisiinijohdannainen ja menetelmä sen valmistamiseksi
PL333414A1 (en) Multivalent salts of pyridostigmin and derivative compounds
EE9700139A (et) Diaminoeetri diklavulanaatsool ja selle valmistamismeetod
FI943212A0 (fi) Hirsielementti ja menetelmä sen valmistamiseksi
FI982635A (fi) Menetelmä ruuvipurkaimen käynnistämiseksi ja ruuvipurkainjärjestelmä
NO971994D0 (no) Vekstmedium of fremgangsmåte
PL314646A1 (en) Novel benzimidasolic salts and method of obtaining them
FI930564A0 (fi) Kartonki ja menetelmä sen valmistamiseksi

Legal Events

Date Code Title Description
FD Application lapsed